rs17853184

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_181507.2(HPS5):​c.3046G>A​(p.Glu1016Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,607,104 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 8 hom. )

Consequence

HPS5
NM_181507.2 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 1.82

Publications

6 publications found
Variant links:
Genes affected
HPS5 (HGNC:17022): (HPS5 biogenesis of lysosomal organelles complex 2 subunit 2) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 6 protein and may interact with the cytoplasmic domain of integrin, alpha-3. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 5. Multiple transcript variants encoding two distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
HPS5 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • Hermansky-Pudlak syndrome without pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_181507.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011577249).
BP6
Variant 11-18283807-C-T is Benign according to our data. Variant chr11-18283807-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 303870.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00139 (212/152292) while in subpopulation AMR AF = 0.00294 (45/15286). AF 95% confidence interval is 0.00226. There are 0 homozygotes in GnomAd4. There are 95 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 8 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181507.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS5
NM_181507.2
MANE Select
c.3046G>Ap.Glu1016Lys
missense
Exon 21 of 23NP_852608.1Q9UPZ3-1
HPS5
NM_001440902.1
c.3046G>Ap.Glu1016Lys
missense
Exon 21 of 24NP_001427831.1
HPS5
NM_001440903.1
c.3046G>Ap.Glu1016Lys
missense
Exon 21 of 24NP_001427832.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS5
ENST00000349215.8
TSL:1 MANE Select
c.3046G>Ap.Glu1016Lys
missense
Exon 21 of 23ENSP00000265967.5Q9UPZ3-1
HPS5
ENST00000396253.7
TSL:1
c.2704G>Ap.Glu902Lys
missense
Exon 20 of 22ENSP00000379552.3Q9UPZ3-2
HPS5
ENST00000438420.6
TSL:1
c.2704G>Ap.Glu902Lys
missense
Exon 20 of 22ENSP00000399590.2Q9UPZ3-2

Frequencies

GnomAD3 genomes
AF:
0.00139
AC:
212
AN:
152174
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00295
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000755
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00215
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00134
AC:
337
AN:
251090
AF XY:
0.00141
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000469
Gnomad NFE exome
AF:
0.00237
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00165
AC:
2399
AN:
1454812
Hom.:
8
Cov.:
29
AF XY:
0.00160
AC XY:
1156
AN XY:
724276
show subpopulations
African (AFR)
AF:
0.000300
AC:
10
AN:
33332
American (AMR)
AF:
0.000984
AC:
44
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000192
AC:
5
AN:
26078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.000534
AC:
46
AN:
86106
European-Finnish (FIN)
AF:
0.00102
AC:
54
AN:
53046
Middle Eastern (MID)
AF:
0.00226
AC:
13
AN:
5762
European-Non Finnish (NFE)
AF:
0.00194
AC:
2140
AN:
1105946
Other (OTH)
AF:
0.00145
AC:
87
AN:
60176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
103
207
310
414
517
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00139
AC:
212
AN:
152292
Hom.:
0
Cov.:
32
AF XY:
0.00128
AC XY:
95
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41564
American (AMR)
AF:
0.00294
AC:
45
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.000755
AC:
8
AN:
10598
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00215
AC:
146
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00176
Hom.:
3
Bravo
AF:
0.00181
EpiCase
AF:
0.00289
EpiControl
AF:
0.00172

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Hermansky-Pudlak syndrome 5 (3)
-
-
2
not provided (2)
-
-
1
HPS5-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T
Eigen
Benign
-0.037
Eigen_PC
Benign
0.14
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.8
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.89
N
REVEL
Benign
0.019
Sift
Benign
0.033
D
Sift4G
Benign
0.061
T
Varity_R
0.13
gMVP
0.41
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs17853184;
hg19: chr11-18305354;
COSMIC: COSV100752392;
COSMIC: COSV100752392;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.